Tang 2015 Subjects with and without 521 stable 5 year All-cause With CKD With CKD: chronic kidney disease (CKD): with CKD mortality 25th 5.2 HR=1.93 (95% CI: 1.13–3.29) total included in analysis=3687 Stage 3+ (466) 50th 7.9 75th 12.4 3166 without Without CKD CKD Without CKD HR=1.47 (95% CI: 1.02–2.12) 25th 2.3 50th 3.4 75th 5.3 Senthong Patients with coronary artery 2235 5 years All-cause 25th 2.5 HR=1.71 (95% CI: 1.11–2.61) 2016b stenosis managed with optimal mortality 50th 3.8 treatment (COURAGE*-like) (338) 75th 6.5 Senthong Patients with history of 821 3 years MACE 25th 2.9 HR=1.74 (95% CI: 1.2–2.51) 2015 and peripheral arterial disease (935) 50th 4.8 Senthong without aortic aneurysm (minus All-cause 75th 8.0 2016a 100) minus no data (14) mortality 5 years HR=1.88 (95% CI:1.21–2.92) (222)
Tang 2015 Subjects with and without chronic kidney disease (CKD): total included in analysis=3687 521 stable with CKD Stage 3+ 3166 without CKD 5 year All-cause mortality (466) With CKD 25th 5.2 50th 7.9 75th 12.4 Without CKD 25th 2.3 50th 3.4 75th 5.3 With CKD: HR=1.93 (95% CI: 1.13–3.29) Without CKD HR=1.47 (95% CI: 1.02–2.12) Senthong 2016b Patients with coronary artery stenosis managed with optimal treatment (COURAGE*-like) 2235 5 years All-cause mortality (338) 25th 2.5 50th 3.8 75th 6.5 HR=1.71 (95% CI: 1.11–2.61) Senthong 2015 and Senthong 2016a Patients with history of peripheral arterial disease (935) without aortic aneurysm (minus 100) minus no data (14) 821 3 years 5 years MACE All-cause mortality (222) 25th 2.9 50th 4.8 75th 8.0 HR=1.74 (95% CI: 1.2–2.51) HR=1.88 (95% CI:1.21–2.92)
A1102%20SD1%20Risk%20and%20technical%20assessment.docx